Uncategorized

Anne Li                    2/9/18   An experimental hormone therapy delays the spread of prostate cancer that has stopped responding to standard treatment, according to new clinical trial results. The drug, called apalutamide, reduced the risk of either the cancer spreading or death…...

Anne Li                        2/9/18   Treatment with an investigational androgen receptor inhibitor significantly delayed the development of metastasis in patients with prostate cancer that had become resistant to standard androgen-deprivation therapy. The results of a multi-institutional, phase 3 clinical trial…...

Anne Li                                           2/9/18   New research from The Scripps Research Institute (TSRI) may give scientists a chance to target tumors before they metastasize. The study, published recently in the Nature…...

Anne Li                                        2/9/18   Long after cancer treatment ends, many continue to deal with one particular symptom that refuses to go away: fatigue. In a new study, researchers at the University…...